IHS Chemical Week

Archives :: Chem Ideas :: Girish Malhotra

Displaying 1 - 12 of 44 stories.
October 22, 2012
Affordability of HIV/AIDS drugs is critical for the well-being and survival of patients especially in underdeveloped countries. Companies have done an excellent job of inventing the...
October 8, 2012
In the last thirty-five years about 351,000 US patents were classified in 424 and 514 class categories, i.e. they are drugs-related. This translates to about 10,000 patents per year. I...
August 7, 2012
The answer to the question is: It depends. This are not the answer one would expect from anyone who is a proponent of continuous processing. Indeed, “it depends” needs...
June 12, 2012
Reading two recent articles in Organic Process Research & Development magazine had me wondering about my chemistry and chemical engineering education and practices. They created a...
May 24, 2012
Quality by Design, or QbD, is targeted at having a robust and repeatable process which produces quality product without rework or re-testing) is financially important for the pharmaceutical industry and highly beneficial for the consumers; as it will ensure quality all the time, and potentially alleviate shortages and lower costs. In order for QbD to become part of the pharma landscape C and E levels of the companies need to have a very clear understanding of cost of regulatory compliance and financial benefits of QbD. Even with the understanding, timely implementation will need considerable cajoling within each company. I am not being opportunistic or pessimistic but being realistic....
April 17, 2012
The answer to the question of whether there could be a revolution to bring about Quality by Design (QbD) in pharmaceutical manufacturing, unequivocally, is yes. But we need some...
March 12, 2012
by Girish Malhotra, president of Epcot International (Pepper Pike, OH) During my career I have been involved in process simplification and cost reduction of different chemistries...
December 14, 2011
The spread of infectious diseases such as HIV/AIDS, malaria, schistosomiasis, and tuberculosis are a cause for global concern. Pharmaceutical companies have developed - and continue to...
November 10, 2011
Little over a month ago Steve Jobs passed away. The tributes that have been forthcoming are breathtaking. This is in spite of his early career shortcomings. Besides creating amazing...
October 18, 2011
Lately we have been reading and hearing shortages of many drugs. As a matter of fact the U.S. FDA on a routine basis publishes the list of drugs that are in short supply. Families and...
September 1, 2011
The U.S. FDA has created a fantastic opportunity for incorporating the best manufacturing technologies in the pharmaceutical hemisphere by charging fees to every generic company...
August 2, 2011
A recent report by a committee comprised of Johnson & Johnson (J&J) board directors essentially gives J&J a clean bill of health for a series of incidents relating to...
Pages:  [1] 2 3 4 5 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa